←
Wansang Cho189 posts
Wansang Cho avatar

Wansang Cho

@ScienceWansang

Postdoc @Stanford Immune cell engineering in @ScienceKyle Lab. BS/PhD @SeoulNatlUni Chemical biology/drug discovery. Build better immunotherapy.

◷ Joined September 2023▧ 1 Photos and videos
Jonathan Kagan avatar
⟳ Wansang Cho retweeted
Jonathan Kagan@jkagan1·Nov 11

The NRF2-KEAP1 regulon is a transcriptional checkpoint for the NLRP3 inflammasome. Very pleased to share our study on how NRF2-KEAP1 links extracellular matrix sensing to NLRP3 regulation. Links to fibrosis, inflammation and cancer are presented. nature.com/articles/s41586-0…

Peter Du avatar
⟳ Wansang Cho retweeted
Peter Du@peterdu_·Sep 19

CRISPR screens are great at telling you what a gene is doing inside your cells. But what if you're interested in what's happening to its neighbors? Today, I'm excited to share match-seq, a new method that deciphers cell-cell interactions using barcoded RNA transfer. 1/9

Post attachment
Heczey Lab avatar
⟳ Wansang Cho retweeted
Heczey Lab@HeczeyLab·Sep 10

Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… @seattlechildren @TexasChildrens @NIH

Robert Kruse, MD, PhD avatar
⟳ Wansang Cho retweeted
Robert Kruse, MD, PhD@RobertLKruse·Sep 1

Thoughts on CAR-T autoimmune deaths: a) Type of autoimmune dz likely matters, given underlying tissue pathology -> potential for adverse events (ex: vasculitis vs rheum). b) Polygenic factors cause autoimmunity, which could influence CAR-T phenotype, area needs to be explored